Searched for
REVLIMID PATENT EXPIRY
Lower GST will re-energise agri and rural sectors: Ashi AnandAshi Anand suggests a GST cut on farm equipment could boost India's rural economy. He believes large-scale tariffs on medicines are unlikel...26 Aug, 2025, 12.15 PM IST- Cipla targets $1 bn US revenue in FY27Cipla aims for $1 billion in US sales by FY27, offsetting Revlimid's patent expiry with new launches, particularly in respiratory generics ...25 Jul, 2025, 10.29 PM IST
- Cipla faces revenue and margin pressure ahead of Revlimid patent expiryCipla faces revenue and margin pressure due to the upcoming Revlimid patent expiry, leading to underperformance and analyst downgrades. Mar...04 Jul, 2025, 06.11 AM IST
- Capacity push and new drugs critical for Aurobindo's healthA delay in drug approvals in the US market remains a concern for Aurobindo. The company stated that eight ANDAs (abbreviated new drug appli...20 Mar, 2025, 06.00 AM IST
- Sumit Gupta remains positive on Cipla and Sun Pharma amid strong US generic market performanceSo, within the generic companies, from the US point of view, Cipla delivered a very good set of results supported by the niche launches. An...18 Feb, 2025, 02.36 PM IST
- Dr Reddy's shares rally 4% as Nuvama upgrades rating to buyDr. Reddy’s Laboratories shares rose 4% after Nuvama upgraded its rating to 'buy,' citing proactive strategies to mitigate the impact of Re...08 Jan, 2025, 11.33 AM IST
- Sun Pharma Q1 preview: Weak Taro show, soft US sales to weigh on earningsConsolidated net profit is seen declining 1.4% YoY to Rs 2,033 crore. India’s largest pharmaceutical company by market capitalization is sc...02 Aug, 2023, 11.42 AM IST
Load More
